[HTML][HTML] Sarilumab use in severe SARS-CoV-2 pneumonia
Background Interleukin-6 signal blockade showed preliminary beneficial effects in treating
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
Sarilumab use in severe SARS-CoV-2 pneumonia.
E Gremese, A Cingolani, SL Bosello, S Alivernini… - …, 2020 - europepmc.org
Background Interleukin-6 signal blockade showed preliminary beneficial effects in treating
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
Sarilumab use in severe SARS-CoV-2 pneumonia
E Gremese, A Cingolani, SL Bosello… - …, 2020 - publicatt.unicatt.it
Background: Interleukin-6 signal blockade showed preliminary beneficial effects in treating
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
[PDF][PDF] Sarilumab use in severe SARS-CoV-2 pneumonia
UOC di Reumatologia - 2020 - researchgate.net
Background: Interleukin-6 signal blockade showed preliminary beneficial effects in treating
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
Sarilumab use in severe SARS-CoV-2 pneumonia
E Gremese, A Cingolani, S Bosello… - …, 2020 - iris.hunimed.eu
Background: Interleukin-6 signal blockade showed preliminary beneficial effects in treating
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
[PDF][PDF] Sarilumab use in severe SARS-CoV-2 pneumonia
umfcs.u-bordeaux.fr
Importance: Interleukin-6 signal blockade has shown preliminary beneficial effects in
treating aberrant host inflammatory response against SARS-CoV-2 leading to severe …
treating aberrant host inflammatory response against SARS-CoV-2 leading to severe …
Sarilumab use in severe SARS-CoV-2 pneumonia
E Gremese, A Cingolani, SL Bosello, S Alivernini… - 2020 - pesquisa.bvsalud.org
ImportanceInterleukin-6 signal blockade has shown preliminary beneficial effects in treating
aberrant host inflammatory response against SARS-CoV-2 leading to severe respiratory …
aberrant host inflammatory response against SARS-CoV-2 leading to severe respiratory …
[HTML][HTML] Sarilumab use in severe SARS-CoV-2 pneumonia
E Gremese, A Cingolani, SL Bosello, S Alivernini… - EClinicalMedicine, 2020 - Elsevier
Background Interleukin-6 signal blockade showed preliminary beneficial effects in treating
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
[PDF][PDF] Sarilumab use in severe SARS-CoV-2 pneumonia
scholar.archive.org
Importance: Interleukin-6 signal blockade has shown preliminary beneficial effects in
treating aberrant host inflammatory response against SARS-CoV-2 leading to severe …
treating aberrant host inflammatory response against SARS-CoV-2 leading to severe …
Sarilumab use in severe SARS-CoV-2 pneumonia
E Gremese, A Cingolani, SL Bosello… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Background Interleukin-6 signal blockade showed preliminary beneficial effects in treating
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …
inflammatory response against SARS-CoV-2 leading to severe respiratory distress. Herein …